Enhancing the efficacy of viral vector blood-stage malaria vaccines
<p>Replication-deficient adenovirus (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This the...
Príomhchruthaitheoir: | Forbes, E |
---|---|
Rannpháirtithe: | Hill, A |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
2011
|
Ábhair: |
Míreanna comhchosúla
Míreanna comhchosúla
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
de réir: Kapulu, MC
Foilsithe / Cruthaithe: (2014) -
Developing novel blood-stage malaria vaccines
de réir: Douglas, AD
Foilsithe / Cruthaithe: (2015) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
de réir: Bauza, K
Foilsithe / Cruthaithe: (2012) -
Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
de réir: de Cassan, S
Foilsithe / Cruthaithe: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
de réir: Elias, SC
Foilsithe / Cruthaithe: (2014)